Action of Antifungal Imidazoles on Staphylococcus Aureus

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1982 Sep 1

PMID 6291453

Citations 15

Authors

I J SUD

D S Feingold

Affiliations

Soon will be listed here.

Abstract

In Staphylococcus aureus, using the imidazoles miconazole and ketoconazole, detailed studies of minimal inhibitory concentrations, kinetics of growth, viability, and release of intracellular K+ confirm that the two imidazoles work differently in this bacterium. Miconazole is bactericidal at low concentrations and causes release of cellular K+. Ketoconazole has no bactericidal effect at any tested concentration and has little effect on K+ permeability of S. aureus; it slows growth at high concentration. This is reflected in a low minimal inhibitory concentration for miconazole and a high one for ketoconazole. The probable mechanisms of the bacteriostatic and bactericidal effects of the imidazoles are discussed in light of these results and the previously described antifungal mechanisms of the drugs. alpha-Tocopherol blocks the action of both imidazoles.

Citing Articles

Co-selection for antibiotic resistance by environmental contaminants.

Murray L, Hayes A, Snape J, Kasprzyk-Hordern B, Gaze W, Murray A NPJ Antimicrob Resist. 2025; 2(1):9.

PMID: 39843965 PMC: 11721650. DOI: 10.1038/s44259-024-00026-7.

The Nonbacterial Microbiome: Fungal and Viral Contributions to the Preterm Infant Gut in Health and Disease.

Wilson A, Bogie B, Chaaban H, Burge K Microorganisms. 2023; 11(4).

PMID: 37110332 PMC: 10144239. DOI: 10.3390/microorganisms11040909.

Antifungal Azoles as Tetracycline Resistance Modifiers in Staphylococcus aureus.

Mahey N, Tambat R, Verma D, Chandal N, Thakur K, Nandanwar H Appl Environ Microbiol. 2021; 87(15):e0015521.

PMID: 33990311 PMC: 8276810. DOI: 10.1128/AEM.00155-21.

A novel mechanism of action of ketoconazole: inhibition of the efflux pump system and biofilm formation in multidrug-resistant .

Abd El-Baky R, Sandle T, John J, Abuo-Rahma G, Hetta H Infect Drug Resist. 2019; 12:1703-1718.

PMID: 31354319 PMC: 6585162. DOI: 10.2147/IDR.S201124.

Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Tatara A, Rozich A, Kontoyiannis P, Watson E, Albert N, Bennett G J Mater Sci Mater Med. 2018; 29(5):70.

PMID: 29752591 PMC: 6009980. DOI: 10.1007/s10856-018-6073-1.

References

Kates M . Bacterial lipids. Adv Lipid Res. 1964; 2:17-90. View

van Cutsem J, THIENPONT D . Miconazole, a broad-spectrum antimycotic agent with antibacterial activity. Chemotherapy. 1972; 17(6):392-404. DOI: 10.1159/000220875. View

Schar G, Kayser F, Dupont M . Antimicrobial activity of econazole and miconazole in vitro and in experimental candidiasis and aspergillosis. Chemotherapy. 1976; 22(3-4):211-20. DOI: 10.1159/000221928. View

Chen W, SUD I, Chou D, Feingold D . Selective toxicity of the polyene antibiotics and their methyl ester derivatives. Biochem Biophys Res Commun. 1977; 74(2):480-7. DOI: 10.1016/0006-291x(77)90329-1. View

De Nollin S, Van Belle H, Goossens F, Thone F, Borgers M . Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother. 1977; 11(3):500-13. PMC: 352013. DOI: 10.1128/AAC.11.3.500. View

VAN DEN BOSSCHE H, Willemsens G, Cools W, Lauwers W, Le Jeune L . Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact. 1978; 21(1):59-78. DOI: 10.1016/0009-2797(78)90068-6. View

SUD I, Feingold D . Lipid composition and sensitivity of Prototheca wickerhamii to membrane-active antimicrobial agents. Antimicrob Agents Chemother. 1979; 16(4):486-90. PMC: 352886. DOI: 10.1128/AAC.16.4.486. View

Yamaguchi H, Iwata K . Effect of fatty acyl group and sterol composition on sensitivity of lecithin liposomes to imidazole antimycotics. Antimicrob Agents Chemother. 1979; 15(5):706-11. PMC: 352741. DOI: 10.1128/AAC.15.5.706. View

SUD I, Chou D, Feingold D . Effect of free fatty acids on liposome susceptibility to imidazole antifungals. Antimicrob Agents Chemother. 1979; 16(5):660-3. PMC: 352925. DOI: 10.1128/AAC.16.5.660. View

10.

VAN DEN BOSSCHE H, Willemsens G, Cools W, Cornelissen F . Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings]. Arch Int Physiol Biochim. 1979; 87(4):849-51. View

11.

Cope J . Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release. J Gen Microbiol. 1980; 119(1):245-51. DOI: 10.1099/00221287-119-1-245. View

12.

SUD I, Feingold D . Mechanisms of action of the antimycotic imidazoles. J Invest Dermatol. 1981; 76(6):438-41. DOI: 10.1111/1523-1747.ep12521036. View

13.

SUD I, Feingold D . Heterogeneity of action of mechanisms among antimycotic imidazoles. Antimicrob Agents Chemother. 1981; 20(1):71-4. PMC: 181635. DOI: 10.1128/AAC.20.1.71. View

14.

Kuroda S, Uno J, Arai T . Target substances of some antifungal agents in the cell membrane. Antimicrob Agents Chemother. 1978; 13(3):454-9. PMC: 352263. DOI: 10.1128/AAC.13.3.454. View